Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company dedicated to the development of innovative therapies to restore, treat and prevent hearing loss, announces the participation of Nawal Ouzren, CEO of Sensorion in several investor meetings
Nawal Ouzren, Chief Executive Officer, will attend the Jefferies Cell and Genetic Medicine Summit in person on September 30, 2022, to be held in New York, USA. On this occasion, she